India’s pharmaceutical industry has long been hailed as the “pharmacy of the world,” supplying life-saving antiretrovirals to Africa and affordable generics to the U.S. Today, that reputation has evolved into something even more strategic — resilience. In his insightful article “The Rupee Prescription,” Rajkumar Mitra highlights how India’s pharma sector is strengthening its domestic base, reducing overdependence on Chinese APIs, and expanding its global influence. With production-linked incentives, bulk drug parks, and backward integration, Indian drugmakers are not only safeguarding supply chains but also reinforcing their indispensable role in global healthcare.

Download the PDF or read this article at: iPHEX-2025-Day_2

pharma click article Download